245 related articles for article (PubMed ID: 25301327)
1. Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism.
Chen Z; Wang O; Nie M; Elison K; Zhou D; Li M; Jiang Y; Xia W; Meng X; Chen S; Xing X
Mol Cell Endocrinol; 2015 Jan; 399():32-42. PubMed ID: 25301327
[TBL] [Abstract][Full Text] [Related]
2. Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency.
Verma N; Jain V; Birla S; Jain R; Sharma A
J Pediatr Endocrinol Metab; 2012; 25(11-12):1185-90. PubMed ID: 23329769
[TBL] [Abstract][Full Text] [Related]
3. Aromatase deficiency, a rare syndrome: case report.
Baykan EK; Erdoğan M; Özen S; Darcan Ş; Saygılı LF
J Clin Res Pediatr Endocrinol; 2013; 5(2):129-32. PubMed ID: 23748068
[TBL] [Abstract][Full Text] [Related]
4. Ovarian and uterine development and hormonal feedback mechanism in a 46 XX patient with CYP19A1 deficiency under low dose estrogen replacement.
Burckhardt MA; Obmann V; Wolf R; Janner M; Flück CE; Mullis PE
Gynecol Endocrinol; 2015 May; 31(5):349-54. PubMed ID: 25585547
[TBL] [Abstract][Full Text] [Related]
5. Aromatase and estrogen receptor α deficiency.
Bulun SE
Fertil Steril; 2014 Feb; 101(2):323-9. PubMed ID: 24485503
[TBL] [Abstract][Full Text] [Related]
6. Aromatase deficiency owing to a functional variant in the placenta promoter and a novel missense mutation in the CYP19A1 gene.
Hauri-Hohl A; Meyer-Böni M; Lang-Muritano M; Hauri-Hohl M; Schoenle EJ; Biason-Lauber A
Clin Endocrinol (Oxf); 2011 Jul; 75(1):39-43. PubMed ID: 21521281
[TBL] [Abstract][Full Text] [Related]
7. Aromatase deficiency: a novel compound heterozygous mutation identified in a Chinese girl with severe phenotype and obvious maternal virilization.
Zhu WJ; Cheng T; Zhu H; Han B; Fan MX; Gu T; Zhao SX; Liu Y; Cheng KX; Song HD; Qiao J
Mol Cell Endocrinol; 2016 Sep; 433():66-74. PubMed ID: 27256151
[TBL] [Abstract][Full Text] [Related]
8. Aromatase deficiency in a male patient - Case report and review of the literature.
Miedlich SU; Karamooz N; Hammes SR
Bone; 2016 Dec; 93():181-186. PubMed ID: 27693882
[TBL] [Abstract][Full Text] [Related]
9. Estrogen deficiency reversibly induces telomere shortening in mouse granulosa cells and ovarian aging in vivo.
Bayne S; Li H; Jones ME; Pinto AR; van Sinderen M; Drummond A; Simpson ER; Liu JP
Protein Cell; 2011 Apr; 2(4):333-46. PubMed ID: 21574023
[TBL] [Abstract][Full Text] [Related]
10. Aromatase excess syndrome in a Chinese boy due to a novel duplication at 15q21.2.
Tan X; Wu X; Chen J; Wu Y; Li S; Chen X; Zhang X
J Pediatr Endocrinol Metab; 2019 Jan; 32(1):85-88. PubMed ID: 30530883
[TBL] [Abstract][Full Text] [Related]
11. A Novel Homozygous
Dursun F; Ceylaner S
J Clin Res Pediatr Endocrinol; 2019 May; 11(2):196-201. PubMed ID: 30074481
[TBL] [Abstract][Full Text] [Related]
12. Impact of estrogen replacement throughout childhood on growth, pituitary-gonadal axis and bone in a 46,XX patient with CYP19A1 deficiency.
Janner M; Flück CE; Mullis PE
Horm Res Paediatr; 2012; 78(4):261-8. PubMed ID: 22964562
[TBL] [Abstract][Full Text] [Related]
13. An aroma of complexity: how the unique genetics of aromatase (CYP19A1) explain diverse phenotypes from hens and hyenas to human gynecomastia, and testicular and other tumors.
Stratakis CA
J Clin Endocrinol Metab; 2013 Dec; 98(12):4676-81. PubMed ID: 24311795
[No Abstract] [Full Text] [Related]
14. Genomic basis of aromatase excess syndrome: recombination- and replication-mediated rearrangements leading to CYP19A1 overexpression.
Fukami M; Tsuchiya T; Vollbach H; Brown KA; Abe S; Ohtsu S; Wabitsch M; Burger H; Simpson ER; Umezawa A; Shihara D; Nakabayashi K; Bulun SE; Shozu M; Ogata T
J Clin Endocrinol Metab; 2013 Dec; 98(12):E2013-21. PubMed ID: 24064691
[TBL] [Abstract][Full Text] [Related]
15. Congenital disorders of estrogen biosynthesis and action.
Fukami M; Ogata T
Best Pract Res Clin Endocrinol Metab; 2022 Jan; 36(1):101580. PubMed ID: 34538723
[TBL] [Abstract][Full Text] [Related]
16. Five new cases of 46,XX aromatase deficiency: clinical follow-up from birth to puberty, a novel mutation, and a founder effect.
Marino R; Perez Garrido N; Costanzo M; Guercio G; Juanes M; Rocco C; Ramirez P; Warman DM; Ciaccio M; Pena G; Feyling JG; Miras M; Rivarola MA; Belgorosky A; Saraco N
J Clin Endocrinol Metab; 2015 Feb; 100(2):E301-7. PubMed ID: 25415177
[TBL] [Abstract][Full Text] [Related]
17. Aromatase Deficiency in Two Siblings with 46,XX Karyotype Raised as Different Genders: A Novel Mutation (p.R115X) in the
Özen S; Atik T; Korkmaz Ö; Onay H; Gökşen D; Özkınay F; Çoğulu Ö; Darcan Ş
J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):109-112. PubMed ID: 30968679
[TBL] [Abstract][Full Text] [Related]
18. Aromatase excess syndrome: a rare autosomal dominant disorder leading to pre- or peri-pubertal onset gynecomastia.
Fukami M; Miyado M; Nagasaki K; Shozu M; Ogata T
Pediatr Endocrinol Rev; 2014 Mar; 11(3):298-305. PubMed ID: 24716396
[TBL] [Abstract][Full Text] [Related]
19. Aromatase Deficiency due to a Homozygous CYP19A1 Mutation in a 46,XX Egyptian Patient with Ambiguous Genitalia.
Mazen I; McElreavey K; Elaidy A; Kamel AK; Abdel-Hamid MS
Sex Dev; 2017; 11(5-6):275-279. PubMed ID: 29324451
[TBL] [Abstract][Full Text] [Related]
20. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene.
Herrmann BL; Saller B; Janssen OE; Gocke P; Bockisch A; Sperling H; Mann K; Broecker M
J Clin Endocrinol Metab; 2002 Dec; 87(12):5476-84. PubMed ID: 12466340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
